An observational post-marketing surveillance study on the status and factors for the development of peripheral neuropathy in patients with HER2-negative inoperable or recurrent breast cancer in Japan (HAL02T) First published 04/09/2014 Last updated 15/11/2019 EU PAS number:EUPAS7424 Study Finalised